[Anonymous (2012). Antineoplastic drugs: Hazardous, handle with care. ONA (Ontario Nurses Association) – Local 100 Newsletter, December, 7–13.]Search in Google Scholar
[Buschini, A., Villarini, M., Feretti, D., Mussi, F., Dominici, L., Zerbini, I., Moretti, M., Ceretti, E., Bonfiglioli, R., Carrieri, M., Gelatti, U., Rossi, C., Monarca, S., Poli, P. (2013). Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: Assessment of DNA damage. Occup. Environ. Med.,70 (11), 789–794.10.1136/oemed-2013-10147524143019]Search in Google Scholar
[Gómez-Olivįn, L. M., Miranda-Mendoza, G. D., Cabrera-Galeana, P. A., Galar-Martínez, M., Islas-Flores, H., SanJuan-Reyes, N., Neri-Cruz, N., García-Medina, S. (2014). Oxidative stress induced in nurses by exposure to preparation and handling of antineoplastic drugs in Mexican hospitals: A multicentric study. Oxid. Med. Cell. Longevity,2014, 7.10.1155/2014/858604395641924719678]Search in Google Scholar
[Keat, C. H., Sooaid, N. S., Yun, C. Y., Sriraman, M. (2013). Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: Pharmacists’ experience in a general hospital, Malaysia. Asian Pacif. J. Cancer Prevent., 14 (1), 69–73.10.7314/APJCP.2013.14.1.69]Search in Google Scholar
[Lawson, C. C., Rocheleau, C. M., Whelan, E. A., Lividoti Hibert, E. N., Grajewski, B., Spiegelman, D., Rich-Edwards, J. W. (2012). Occupational exposures and spontaneous abortion. Amer. J. Obstetrics Gynecol., 206 (4), e1–e8.]Search in Google Scholar
[Momeni, M., Danaei, M., Askarian, M. (2013). How do nurses manage their occupational exposure to cytotoxic drugs? A descriptive survey in chemotherapy settings, Shiraz, Iran. Int. J. Occup. Environ. Med., 4 (2), 102–106.]Search in Google Scholar
[Anonymous (2014). NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2014. U.S. Department of Health and Human Services Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2014-138.]Search in Google Scholar
[Shahrasbi, A. A., Afshar, M., Shokraneh, F., Monji, F., Noroozi, M., Ebrahimi-Khojin, M., Madani, S. F., Ahadi-Barzoki, M., Rajabi, M. (2014). Risks to health professionals from hazardous drugs in Iran: A pilot study of understanding of healthcare team to occupational exposure to cytotoxics. Exper. Clin. Sci. Int. Online J. Adv. Sci.,13, 491–501.]Search in Google Scholar
[Villarini, M., Dominici, L., Fatigoni, C., Muzi, G., Monarca, S., Moretti, M. (2012). Biological effect monitoring in peripheral blood lymphocytes from subjects occupationally exposed to antineoplastic drugs: Assessment of micronuclei frequency. J. Occup. Health, 54 (9), 405–415.10.1539/joh.12-0038-OA22986622]Search in Google Scholar
[Yu Wen, H., Le, J., Mei, Bian, Z. Quan, Z., Xiao Feng, Y., Xu Dong, H., Ying, Z., Ji Liang, H. (2012). An investigation of oxidative DNA damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay. Biomed. Environ. Sci.,25 (1), 109–116.]Search in Google Scholar